from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0267/narU

LFCtreatmentdescriptionclass of inhibitor

0.791

Amikacinug/mL Amikacintranslation

-0.355

Cap5-10ug/mL Capreomycintranslation

0.199

Rox10-50 ug/mL Roxithromycintranslation

-0.518

SM2-5 ug/mL Streptomycintranslation

0.083

Tet5-10 ug/mL Tetracyclinetranslation

1.308

Rif0.2-5ug/mL Rifampicintranscription

0.395

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.490

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.557

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.200

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.384

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.737

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.394

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.593

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.471

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-2.222

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.041

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.460

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.488

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.990

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.293

KCN5-20 ug/mL Potassium cyaniderespiration

-0.521

NaN30.2-2 mM Sodium aziderespiration

-0.400

Nigericin50 uM Nigericinrespiration

0.360

TRC10-150 ug/mL Triclosanrespiration

1.579

TRZ10-25 ug/mL Thioridazinerespiration

-0.260

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.179

menadione6-10 ug/mL Menadionerespiration

0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.532

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.397

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.752

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.506

NRP_1Non-replicating persistence stage 1dosRassociated

-0.832

Amp0.2mg/mL AmpicillincellWall

-0.301

Cephalexin20-100 ug/mL CephalexincellWall

-0.585

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.328

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.109

EMB10-20 ug/mL EthambutolcellWall

-0.245

Eta12-40 ug/mL EthionamidecellWall

0.093

INH0.2-0.4 ug/mL IsoniazidcellWall

0.135

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.489

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.776

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.105

BZA0.12 mg/mL BenzamidearomaticAmides

-0.167

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.549

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.348

H2O24 mM hydrogen peroxideDNAdamaging

0.115

Levo10 ug/mL LevofloxacinDNAdamaging

-0.777

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.442

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.252

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.982

UVUV-irradiationDNAdamaging

1.418

ARP41-4 ug/mL Antitubercular compound ARP4?

0.229

Antimycin12.5-50 ug/mL Antimycin A?

-0.211

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.685

PA_110-50 ug/mL Antitubercular compound PA-1?

0.508

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.140

PA8240.2-2 ug/mL PA-824?

0.270

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.539

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.048

Verapamil50 uM Verapamil?

0.061

mercaptoethanol2 mM 2-Mercaptoethanol?

0.973

methoxatin10-20 ug/mL Methoxatin?